Obstructive Sleep

Apnoea Obstructive Sleep Apnoea (OSA) is a sleep disorder characterised by pauses in breathing while sleeping, caused by a blocking of the upper airway. It is estimated to affect around 4% of the population and is associated with numerous health risks, such as high blood pressure, heart disease and diabetes. It is also associated with increased risk of stroke and can even have an impact on an individual’s daytime sleepiness and cognitive performance. OSA is diagnosed using several different criteria, such as an overnight sleep study and/or other tests, and can be treated using lifestyle changes, medical treatments and surgical procedures. These treatments are important for promoting health, reducing symptoms, improving quality of life and reducing the potential long-term health risks associated with OSA.